Gastroenterology
Volume 133, Issue 5 , Pages 1452-1457 , November 2007

Clearance of Hepatitis B e Antigen in Patients With Chronic Hepatitis B and Genotypes A, B, C, D, and F

  • Stephen E. Livingston

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • Corresponding Author InformationAddress requests for reprints to: Stephen E. Livingston, MD, Alaska Native Tribal Health Consortium, Liver Disease & Hepatitis Program, 4315 Diplomacy Drive, ANC-HEP, Anchorage, Alaska 99508. fax: (907) 729-1570.
    • ,
  • Josephine P. Simonetti

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • ,
  • Lisa R. Bulkow

      Affiliations

    • Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska
    • ,
  • Chriss E. Homan

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • ,
  • Mary M. Snowball

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • ,
  • Henry H. Cagle

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • ,
  • Susan E. Negus

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • ,
  • Brian J. McMahon

      Affiliations

    • Liver Disease & Hepatitis Program, Alaska Native Tribal Health Consortium, Anchorage, Alaska
    • Arctic Investigations Program, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, Alaska

Received 18 May 2007 ,Accepted 26 July 2007.

References 

  1. Lee W. Hepatitis B virus infection. N Engl J Med. 1997;337:1733–1745
  2. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11:97–107
  3. Stevens CE, Beasley RP, Tsui J, et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771–774
  4. McMahon BJ, Alward WLM, Hall DB, Heyward WL, Bender TR, Francis DP, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151:599–603
  5. Chang MH. The natural history of hepatitis B virus infection in children. J Gastroenterol Hepatol. 2000;15(Suppl):E16–E19
  6. Kao J-H. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643–650
  7. Arauz-Ruiz P, Norder H, Robertson B, Magnius L. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol. 2002;82:2059–2073
  8. Chi-Jen KC, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology. 2002;122:1756–1762
  9. Sumi H, Yokosuka O, Seki N, Arai M, Imazeki F, Kurihara T, et al. Influence of hepatitis B virus genotypes on the progression of chronic type B liver disease. Hepatology. 2003;37:19–26
  10. Watanabe K, Takahashi T, Takahashi S, Okoshi S, Ichida T, Aoyagi Y. Comparative study of genotype B and C hepatitis B virus–induced chronic hepatitis in relation to the basic core promoter and precore mutations. J Gastroenterol Hepatol. 2005;20:441–449
  11. Chan HL-Y, Hui AY, Wong ML, Tse AM-L, Hung LC-T, Wong VW-S, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut. 2004;53:1494–1498
  12. Thakur V, Guptan RC, Kazim SN, Malhotra V, Sarin SK. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol. 2002;17:165–170
  13. McMahon BJ, Schoenberg S, Bulkow L, Wainwright RB, Fitzgerald MA, Parkinson AJ, et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol. 1993;138:544–549
  14. McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Int Med. 2001;135(9):759–768
  15. Livingston SE, Simonetti JP, McMahon BJ, Bulkow LR, Hurlburt KJ, Homan CE, et al. Hepatitis B virus genotypes in Alaska Native people with hepatocellular carcinoma: preponderance of genotype F. J Infect Dis. 2007;195:5–11
  16. Chen DS, Hsu NH, Sung JL, Hsu TC, Hsu ST, Kuo YT, et al. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers. JAMA. 1987;257:2597–2603
  17. Sung JL. Hepatitis B virus eradication strategy for Asia (The Asian Regional Study Group). Vaccine. 1990;8(Suppl):S95–S99
  18. Botha JF, Ritchie MJ, Dusheiko GM, Mounton HW, Kew MC. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet. 1984;1:1210–1212
  19. Esteroff DT, Greenman JA, Heyward WL, McMahon BJ, Hardison HH, Bender TR. Increased prevalence of hepatitis B surface antigen in pregnant Alaskan Eskimos. In:  Fortuine RF editors. Circumpolar health 84. Seattle, WA: University of Washington Press; 1985;p. 206–208
  20. Kramvis A, Kew M, Francois G. Hepatitis B virus genotypes. Vaccine. 2005;23:2409–2423
  21. Lok ASF, McMahon BJ. Chronic hepatitis B: AASLD practice guidelines. Hepatology. 2007;45:507–539

 Supported by Native American Research Centers for Health (NARCH) grant 1 U26 94 00005-01 from the US Indian Health Services.

PII: S0016-5085(07)01456-4

doi: 10.1053/j.gastro.2007.08.010

Gastroenterology
Volume 133, Issue 5 , Pages 1452-1457 , November 2007

Article Tools

* Image Usage & Resolution